This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
Announcement: Appointment of Drug Hunter Advisory Board Member: Wendy Young, Ph. D. Drug Hunter is pleased to introduce a new member of our…
Article
1 year ago ●
3 mins read
Context. “Compound 14” (Shionogi Pharmaceuticals) is a nicotinamide N-methyltransferase (NNMT) inhibitor. For some “difficult to drug” targets such as protein-protein…
molecule
7 months ago ●
4 mins read
Announcement: Appointment of Drug Hunter Advisory Board Member: Andrew Setikas Drug Hunter is pleased to introduce a new member of our Advisory Board,…
Article
1 year ago ●
3 mins read
Context. CC-99677 (BMS) is an oral, covalent MAPK–activated protein kinase-2 (MK2) inhibitor being developed for autoimmune diseases. Although p38 is…
molecule
7 months ago ●
4 mins read
Announcement: Appointment of Drug Hunter Advisory Board Member: Gary Yeung, CFA Drug Hunter is pleased to introduce a new member of our Advisory…
Article
1 year ago ●
2 mins read
Context. “Compound 23” (LEO Pharma) is an oral IL-17A protein−protein interaction modulator being developed for psoriasis and other inflammatory diseases.…
molecule
8 months ago ●
5 mins read
Load More
